The influence of the apolipoprotein E gene promoter (-219G/T) polymorphism on postprandial lipoprotein metabolism in young normolipemic males

Journal of Lipid Research

Volumn 44, Issue 11, 2003, Pages 2059-2064

  Moreno, Juan Antonio ^a   López Miranda, José ^a   Marín, Carmen ^a   Gómez, Purificación ^a   Pérez Martínez, Pablo ^a   Fuentes, Francisco ^a   Fernández De La Puebla, Rafael Angel ^a   Paniagua, Juan Antonio ^a   Ordovas, José Maria ^b   Pérez Jiménez, Francisco ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Cholesterol; Postprandial lipemia; Retinyl palmitate; Triacylglycerol rich lipoproteins; Triacylglycerols

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; CHOLESTEROL; RETINOL; RETINOL PALMITATE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BODY SURFACE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FAT INTAKE; GENETIC ANALYSIS; GENOTYPE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; APOLIPOPROTEINS E; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD; PROMOTER REGIONS (GENETICS);

EID: 0344236147     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300124-JLR200     Document Type: Article

References (28)

1. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
2. Weisgraber, K. H. 1994. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45: 249-302.
3. Davignon, J., R. E. Gregg, and C. F. Sing. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8: 1-21.
4. Luc, G., J. M. Bard, D. Arveiler, A. Evans, J. P. Cambou, A. Bingham, P. Amouyel, P. Schaffer, J. B. Ruidavets, F. Cambien. 1994. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler. Thromb. 14: 1412-1419.
5. Nakai, K., T. Fusazaki, T. Zhang, T. Shiroto, M. Osawa, J. Kamata, M. Itoh, K. Nakai, W. Habano, T. Kiuchi, S. Yamamori, and K. Hiramori. 1998. Polymorphism of the apolipoprotein E and angiotensin I converting enzyme genes in Japanese patients with myocardial infarction. Coron. Artery Dis. 9: 329-334.
6. Lambert, J. C., J. Perez-Tur, M. J. Dupire, D. Galasko, D. Mann, P. Amouyel, J. Hardy, A. Delacourte, and M. C. Chartier-Harlin. 1997. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum. Mol. Genet. 6: 2151-2154.
7. Artiga, M. J., M. J. Bullido, I. Sastre, M. Recuero, M. A. Garcia, J. Aldudo, J. Vazquez, and F. Valdivieso. 1998. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett. 421: 105-108.
8. Lambert, J. C., F. Pasquier, D. Cottel, B. Frigard, P. Amouyel, and M. C. Chartier-Harlin. 1998. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum. Mol. Genet. 7: 533-540.
9. Lambert, J. C., T. Brousseau, V. Defosse, A. Evans, D. Aveiler, J. B. Ruidavets, B. Haas, J. P. Cambou, G. Luc, P. Ducimetiere, F. Cambien, M. C. Chartier-Harlin, and P. Amouyel. 2000. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations - the ECTIM study. Hum. Mol. Genet. 9:57-61.
10. Viitanen, L., J. Pihlajamaki, R. Miettinen, P. Karkkainen, I. Vauhkonen, P. Halonen, A. Kareinen, S. Lehto, and M. Laakso. 2001. Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease. J. Mol. Med. 79: 732-737.
11. Zilversmit, D. B. 1979. Atherogenesis: a postprandial phenomenon. Circulation. 60: 473-485.
12. Ginsberg, H. N., J. Jones, W. S. Blaner, A. Thomas, W. Karmally, L. Fields, D. Blood, and M. D. Begg. 1995. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb. Vasc. Biol. 15: 1829-1838.
13. Patsch, J. R., G. Miesenbock, T. Hopferwieser, V. Muhlberger, E. Knapp, J. K. Dunn, A. M. Gotto, Jr., and W. Patsch. 1992. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 12: 1336-1345.
14. Groot, P. H., W. A. van Stiphout, X. H. Krauss, H. Jansen, A. van Tol, E. van Ramshorst, S. Chin-On, A. Hofman, S. R. Cresswell, and L. Havekes. 1991. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler. Thromb. 11: 653-662.
15. Kugiyama, K., H. Doi, K. Takazoe, H. Kawano, H. Soejima, Y. Mizuno, R. Tsunoda, T. Sakamoto, T. Nakano, K. Nakajima, H. Ogawa, S. Sugiyama, M. Yoshimura, and H. Yasue. 1999. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 99: 2858-2860.
16. Boerwinkle, E., S. Brown, A. R. Sharrett, G. Heiss, and W. Patsch. 1994. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am. J. Hum. Genet. 54: 341-360.
17. Marin, C., J. Lopez-Miranda, P. Gomez, E. Paz, P. Perez-Martinez, F. Fuentes, J. A. Jimenez-Pereperez, J. M. Ordovas, and F. Perez-Jimenez. 2002. Effects of the human apolipoprotein A-I promoter G-A mutation on postprandial lipoprotein metabolism. Am. J. Clin. Nutr 76: 319-325.
18. Ostos, M. A., J. Lopez-Miranda, J. M. Ordovas, C. Marin, A. Blanco, P. Castro, F. Lopez-Segura, J. Jimenez-Pereperez, and F. Perez-Jimenez. 1998. Dietary, fat clearance is modulated by genetic variation in apolipoprotein A-IV gene locus. J. Lipid Res. 39: 2493-2500.
19. Bucolo, G., and H. David. 1973. Quantitative determination of serum triglycerides by use of enzymes. Clin. Chem. 19: 476-482.
20. Allain, C. C., L. S. Poon, C. S. G. Chang, W. Richmond, and P. C. Fu. 1974. Enzymatic determination of total serum cholesterol, Clin. Chem. 20: 470-475.
21. Riepponen, P., J. Marniemi, and T. Rautaoja. 1987. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand. J. Clin. Lab. Invest. 47: 739-744.
22. Warnick, R., J. Benderson, and J. J. Albers. 1982. Dextran sulfate-Mg precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
23. Ruotolo, G., H. Zhang, V. Bentsianov, and N-A. Le. 1992. Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia. J. Lipid Res. 33: 1541-1549.
24. De Ruyter, M. G. M., and A. P. De Leeheer. 1978. Simultaneous determination of retinol and retinyl esters in serum or plasma by reversed-phase high performance liquid chromatography. Clin. Chem. 24: 1920-1923.
25. Karpe, F., and A. Hamsten. 1994. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid Res. 35: 1311-1317.
26. Tsukamoto, K., T. Watanab, T. Matsushima, M. Kinoshita, H. Kato, Y. Hashimoto, K. Kurokawa, and T. Teramoto. 1993. Determination by PCR-RFLP of apo E genotype in a Japanese population. J. Lab. Clin. Med. 121: 598-602.
27. Hodis, H. N. 1999. Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation. 99: 2852-2854.
28. Yu, K. C., and A. D. Cooper. 2001. Postprandial lipoproteins and atherosclerosis. Front. Biosci. 6: 332-354.